Bachar Keren, Shulimzon Tiberiu, Segel Michael J
Institute of Pulmonology, Sheba Tel-HaShomer Medical Center, Ramat Gan, Israel; Medical Corps, Israel Defense Forces, Israel.
Institute of Pulmonology, Sheba Tel-HaShomer Medical Center, Ramat Gan, Israel.
Respir Med. 2022 Dec;205:107036. doi: 10.1016/j.rmed.2022.107036. Epub 2022 Nov 1.
Nontuberculous mycobacterial (NTM) pleuritis is an uncommon manifestation of NTM infection. Case reports and small case series have shown a variable clinical course and high mortality rates.
To describe patients' characteristics, clinical presentation and outcomes of NTM pleural infections.
A systematic review of cases of NTM pleural infections published in PubMed-indexed journals from 1980 to 2021.
A total of 206 cases of NTM pleural infections were found and analyzed. Fifty-eight percent of cases were males. The mean age was 57.5 yrs (range 9-87 yrs). Forty-three percent of patients were immunosuppressed, and 43% had a chronic lung disease; thirty-two percent had neither risk factor. In addition to the pleural infection, 67% of cases had a concurrent pulmonary NTM infection, and in 18 cases there was another extrapulmonary site of NTM infection. In 29% of cases the pleural infection was the sole manifestation of NTM disease. The most common isolated mycobacterium was Mycobacterium avium complex (65%). Fifty-three percent and 26% of patients required pleural effusion drainage and a surgical intervention, respectively, to treat the infection, in addition to anti-NTM chemotherapy. Forty percent of patients developed pneumothorax, 16% suffered from empyema, and 16.5% had broncho-pleural fistula. The reported mortality rate was 24%.
NTM pleural infections may arise in immunocompetent and immunosuppressed patients, with or without chronic lung disease or concurrent NTM pulmonary infection. These infections carry a poor prognosis and a high risk of complications requiring surgical interventions in addition to anti-NTM chemotherapy.
非结核分枝杆菌(NTM)胸膜炎是NTM感染的一种罕见表现。病例报告和小型病例系列显示临床病程多变且死亡率高。
描述NTM胸膜感染患者的特征、临床表现和结局。
对1980年至2021年发表在PubMed索引期刊上的NTM胸膜感染病例进行系统综述。
共发现并分析了206例NTM胸膜感染病例。58%的病例为男性。平均年龄为57.5岁(范围9 - 87岁)。43%的患者免疫功能低下,43%患有慢性肺病;32%既无危险因素。除胸膜感染外,67%的病例同时存在肺部NTM感染,18例存在NTM肺外其他部位感染。29%的病例中胸膜感染是NTM疾病的唯一表现。最常分离出的分枝杆菌是鸟分枝杆菌复合群(65%)。除抗NTM化疗外,分别有53%和26%的患者需要胸腔积液引流和手术干预来治疗感染。40%的患者发生气胸,16%发生脓胸,16.5%发生支气管胸膜瘘。报告的死亡率为24%。
NTM胸膜感染可发生在免疫功能正常和免疫功能低下的患者中,无论有无慢性肺病或同时存在NTM肺部感染。这些感染预后不良,除抗NTM化疗外,还存在较高的并发症风险,需要手术干预。